(2E)-3-(4-ethoxyphenyl)-1-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 2g

Ethylenediamine-n,n'-diacetic acid, 95.0%, 1g

Di-p-tolylphosphine oxide, 95.0%, 100g

anti-Keratin K7 mouse monoclonal, Ks7.18, 0.2 ml

4-Bromo-3-fluoro-2-hydroxybenzaldehyde, 97%, 250mg

2,7-Dibromopyrene, 95.0%, 1g

4-(4-(Tert-butoxycarbonyl)piperazin-1-yl)-2-fluorobenzoic acid, 98%, 250mg

(3-HYDROXYBENZOYLAMINO)ACETIC ACID, 97.0%, 1g

3-Chlorothiophene-2-carbaldehyde, 99.0%, 25g

1-(Hydroxymethyl)cyclopentane-1-carboxylic acid, 97%, 100mg

N-(tert-butyl)-2-(1-piperazinyl)acetamide dihydrochloride, 95.0%, 1g

Ethyl 1,3-dithiane-2-carboxylate, 95.0%, 1g

(R)-1-(5-Bromo-2-fluorophenyl)ethan-1-ol, 98%, 250mg